CBD Company - Endoca
| Ranking and Market Share | #13 - 1.4% of overall market. 2018 sales: $8.6 million; 2017 sales: $6.0 million |
| Product Portfolio | Tinctures (oil), capsules, skin care prodcuts, edibles (gum), suppositories, highly-concentrated raw extract |
| Distribution Channels | Online, independent pharmacies, supplement stores, yoga studios, dispensaries |
| Positioning | High-quality, organic extracts that have been successful around Europe (where company is headquartered) and have a good following in the U.S. and elsewhere internationally, bolstered by solid online presence |
Strengths
| Competitive Advantages | Strong foothold in Europe, U.S. and expanding into Australia (distribution agreement with publicly held Hydroponics Company) |
| Making the most money on | Tinctures, capsules |
| Doing well | Establishing and growing name in Europe; Online referral program providing commissions to referring parties |
Opportunities
| Beneficial trends | Growing CBD interest in Europe; Word of mouth ("network marketing") supporting online affiliate program |
Aspirations and Results
| Who do they want to be? | The best-known and most reputable CBD manufacturer worldwide |
| Chief competitors | Medical Marijuana Inc., Elixinol, MyDailyChoice (HempWorx) |